Skip to content

Survey of daily life difficulties in patients with tardive dyskinesia

Survey of factors affecting QOL in patients with tardive dyskinesia - Survey of factors affecting QOL in patients with tardive dyskinesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045565
Enrollment
100
Registered
2021-09-27
Start date
2021-10-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tardive dyskinesia

Interventions

None listed

Sponsors

Mitsubishi Tanabe Pharm Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients who provide their informed consent to participate in this study -Patients who are 20 or older and diagnosed with tardive dyskinesia (DSM-5 code: 333.85) based on DSM-5 criteria -Patients who have self-awareness of their involuntary movements

Exclusion criteria

Exclusion criteria: -Patients who are judged inappropriate as the subject by researchers -Patients who withdraw their consent to participate in this study

Design outcomes

Primary

MeasureTime frame
-VAS Score -Annoyances (Activities that make you feel distress)

Secondary

MeasureTime frame
-Average score for each question

Countries

Japan

Contacts

Public ContactYumi Watanabe

Mitsubishi Tanabe Pharma Corporation Medical Intelligence department

watanabe.yumi@mf.mt-pharma.co.jp06-6205-5417

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026